4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-038510
EVP, Research & CSO sold 3,510 shares at an average $38.00 ($133,384)
- EVP, Research & CSO acquired 3,510 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-06-19 | Option exercise | +3,510 | $1.53 | $5,370 | 3,510 | D |
| Virgin Herbert EVP, Research & CSO | 2020-06-19 | Sale | −1,755 | $38.00 | $66,694 | 1,755 | D |
| Virgin Herbert EVP, Research & CSO | 2020-06-19 | Sale | −1,755 | $38.00 | $66,690 | 0 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2020-06-19 | Option exercise · Stock Option (Right to Buy) | −3,510 | 538,875 | D | ||
| Open-market sales · 3,510 sh · avg $38.00 · $133,384 | |||||||
Loading xslF345X03/doc4.xml…